Vitiligo Treatment Market Size, Share and Industry Analysis By Treatment (Topical Treatment, Light Therapy, Surgical Procedures, Others), By Disease Type (Nonsegmental Vitiligo, Segmental Vitiligo), By End User (Hospitals, Aesthetic Clinics, Others) and Regional Forecast, 2020 - 2029 (Includes COVID-19 Business Impact)

                                          
We have updated Vitiligo Treatment Market with respect to COVID-19 Business Impact.
Inquire before buying


This report focuses on the Vitiligo Treatment market and value at the global level, regional level, and company level. From a global perspective, this report represents the overall Vitiligo Treatment market size by analyzing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America.


Global Vitiligo Treatment Market: Segment Analysis


The research report includes specific segments by region (country), by Company, by Type, and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2019 to 2029. An in-depth analysis of the segments assists in identifying the different factors that will aid market growth.


Global Vitiligo Treatment Market: Regional Analysis


The research report includes a detailed study of regions of North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America. The report has been curated after observing and studying various factors that determine regional growth such as the economic, environmental, social, technological, and political status of the particular region. Researchers have studied the data of revenue, sales, and manufacturers of each mentioned region. This section analyses region-wise revenue and volume for the forecast period of 2019 to 2029.


Global Vitiligo Treatment Market: Competitive Landscape


This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2019 to 2029.
List of Companies Profiled

  
Incyte Corporation
  
Astellas Pharma Inc.
  
Bausch Health Companies Inc.
  
Baxter International Inc.
  
Pfizer Inc.
  
STRATA Skin Sciences
  
Reddys Laboratories Ltd.
  
Other players

Report Coverage

According to the American Academy of Dermatology (AAD), vitiligo affects an estimated one in four individuals in the U.S. Also, an estimated 1%-2% of the global population is estimated to be suffering from vitiligo. This large patient pool suffering from vitiligo, combined with increasing demand for advanced treatment options, is leading to rising demand for vitiligo treatment globally. The anticipated introduction of new products in the market, along with an increasing number of patients undergoing vitiligo treatment globally is projected to further augment the demand for vitiligo treatment during the forecast period.

The vitiligo treatment market report provides qualitative and quantitative insights on the industry trends and detailed analysis of market size and growth rate for all possible segments in the market. The market segments include treatment, disease type, end user, and geography. On the basis of the treatment, the vitiligo treatment market segments include topical treatment, light therapy, surgical procedures, and others. Based on disease type, the global market is segmented into nonsegmental vitiligo, and segmental vitiligo. Based on end user, the market is segmented into hospitals, aesthetic clinics, and others. Geographically, the market is segmented into five major regions, which are North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The regions are further categorized into countries.

Along with this, the report analysis includes market dynamics and competitive landscape. Various key insights provided in the report are the prevalence of vitiligo by key countries, overview of pipeline analysis, recent industry developments such as mergers & acquisitions, recent developments in R&D, and others.
SEGMENTATION

 SEGMENTATION

By Treatment

  
Topical Treatment
  
Light Therapy
  
Surgical Procedures
  
Others

By Disease Type

  
Nonsegmental Vitiligo
  
Segmental Vitiligo

By End User

  
Hospitals
  
Aesthetic Clinics
  
Others

By Geography

  
North America (the USA and Canada)
  
Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
  
Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  
Latin America (Brazil, Mexico and Rest of Latin America)
  
Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa)

Key Industry Developments

In June 2019, Incyte reported positive results from a Phase 2 study of ruxolitinib cream in patients suffering from vitiligo

In June 2014, Dr. Reddys announced the launch of Melgain lotion, the first peptide-based drug for the treatment of vitiligo in India